Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DNA TWOPOINTO INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-20 to 2023-06-11
Current total value of award: $68094.65
Description: DNA TWOPOINTO, INC. (ATUM) HAS "EVALUATION LICENSE AND MATERIALS: CELL LINE DEVELOPMENT EXPRESSION VECTOR OPTIMIZATION" NEEDED BY NIAID'S VACCINE RESEARCH CENTER.